GSA Capital Partners’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,268
| Closed | -$147K | – | 1958 |
|
|
2024
Q4 | $147K | Buy |
+25,268
| New | +$147K | 0.01% | 1474 |
|
|
2024
Q2 | – | Sell |
-27,013
| Closed | -$306K | – | 1926 |
|
|
2024
Q1 | $306K | Sell |
27,013
-17,227
| -39% | -$195K | 0.02% | 1206 |
|
|
2023
Q4 | $621K | Sell |
44,240
-15,533
| -26% | -$218K | 0.05% | 649 |
|
|
2023
Q3 | $738K | Sell |
59,773
-42,067
| -41% | -$519K | 0.06% | 563 |
|
|
2023
Q2 | $920K | Sell |
101,840
-128,792
| -56% | -$1.16M | 0.09% | 361 |
|
|
2023
Q1 | $800K | Sell |
230,632
-1,001
| -0.4% | -$3.47K | 0.08% | 439 |
|
|
2022
Q4 | $568K | Buy |
231,633
+127,549
| +123% | +$313K | 0.07% | 527 |
|
|
2022
Q3 | $287K | Buy |
+104,084
| New | +$287K | 0.04% | 962 |
|
|
2022
Q2 | – | Sell |
-72,287
| Closed | -$308K | – | 1690 |
|
|
2022
Q1 | $308K | Buy |
72,287
+32,060
| +80% | +$137K | 0.04% | 874 |
|
|
2021
Q4 | $377K | Buy |
+40,227
| New | +$377K | 0.05% | 784 |
|